1.
Besins Healthcare [Internet]. 2016. Besins Healthcare México [Consultado el 16 de Abril 2018]. Disponible en: http:// www.besins-healthcare.com.mx
2.
Smitz J, et al. A prospective randomized comparison of intramuscular or intravaginal natural progesterone as a luteal phase and early pregnancy supplement. Hum Reprod.1992; 7(2): 168–75.
3.
Información Para Prescribir de Utrogestan®
4.
Cedars ML. Progesterone: Uses in ART and prevention of pregnancy loss. J Fam Pract. 2007: 9-13.
5.
National Institute for Health and Care Excellence. Preterm labour and birth. NICE guideline. 2015: 1-27.
6.
Sánchez O, et al. Parto Pretérmino. Guía de Práctica Clínica. COMEGO. 2015. Pp: 250-90.
7.
Fonseca EB. et. al. Progesterone and the risk of preterm birth among women with a short cérvix. N Engl J Med. 2007; 357: 462-9.
8.
Proctor A, et al. Effect of progesterone supplementation in early pregnancy on the pregnancy outcome after in vitro fertilization. Fertil Steril. 2006; 85(5): 1550-52.
9.
López-Castrejón A, et al. Hemorragia uterina disfuncional de la adolescencia y su tratamiento con prosterona micronizada. Toko-Gin Pract. 2004; 63(4): 315-9.
10.
Simón JA. Introduction: An overview of progesterone and progestins. J Fam Pract 2007: 3-5.
11.
Jiang Y, et al. The effects of progesterones on blood lipids in hormone replacement therapy. Lipids Health Dis. 2017; 16(1): 1-8
Utrogestan®
el estándar
de oro
REFERENCIAS
IRREGULARIDADES MENSTRUALES
FERTILIDAD
PREVENCIÓN DE PARTO PRE-TÉRMINO
AMENAZA DE ABORTO